98 related articles for article (PubMed ID: 17591830)
1. Dasatinib: a new step in molecular target therapy.
Olivieri A; Manzione L
Ann Oncol; 2007 Jun; 18 Suppl 6():vi42-6. PubMed ID: 17591830
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia.
Haslam S
Core Evid; 2005; 1(1):1-12. PubMed ID: 22496672
[TBL] [Abstract][Full Text] [Related]
3. Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib.
Chuah C; Melo JV
Onco Targets Ther; 2009 Feb; 2():83-94. PubMed ID: 20616897
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.
McCormack PL; Keam SJ
Drugs; 2011 Sep; 71(13):1771-95. PubMed ID: 21902298
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles Effectively Target Rapamycin Delivery to Sites of Experimental Aortic Aneurysm in Rats.
Shirasu T; Koyama H; Miura Y; Hoshina K; Kataoka K; Watanabe T
PLoS One; 2016; 11(6):e0157813. PubMed ID: 27336852
[TBL] [Abstract][Full Text] [Related]
7. Acquired Factor VIII Deficiency in Chronic Myeloid Leukemia: A Case Report.
Hassan WU; Ahmad M; Abdelazeem B; Koduru U; Kunadi A
Cureus; 2023 Nov; 15(11):e48802. PubMed ID: 38098897
[TBL] [Abstract][Full Text] [Related]
8. New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study.
Fakhry MM; Mattar AA; Alsulaimany M; Al-Olayan EM; Al-Rashood ST; Abdel-Aziz HA
Molecules; 2023 Nov; 28(21):. PubMed ID: 37959874
[No Abstract] [Full Text] [Related]
9. The Progress of Small Molecule Targeting BCR-ABL in the Treatment of Chronic Myeloid Leukemia.
Zhang Y; Wu X; Sun X; Yang J; Liu C; Tang G; Lei X; Huang H; Peng J
Mini Rev Med Chem; 2024; 24(6):642-663. PubMed ID: 37855278
[TBL] [Abstract][Full Text] [Related]
10. Anti-Cancer Effects of Oxygen-Atom-Modified Derivatives of Wasabi Components on Human Leukemia Cells.
Lin JF; Chi CW; Huang YC; Tsai TH; Chen YJ
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047794
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics.
Bulbiankova D; Díaz-Puertas R; Álvarez-Martínez FJ; Herranz-López M; Barrajón-Catalán E; Micol V
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36830002
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.
Singha M; Pu L; Stanfield BA; Uche IK; Rider PJF; Kousoulas KG; Ramanujam J; Brylinski M
BMC Cancer; 2022 Nov; 22(1):1211. PubMed ID: 36434556
[TBL] [Abstract][Full Text] [Related]
13. Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells.
Fakhry MM; Mahmoud K; Nafie MS; Noor AO; Hareeri RH; Salama I; Kishk SM
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297358
[TBL] [Abstract][Full Text] [Related]
14. Nilotinib modulates LPS-induced cognitive impairment and neuroinflammatory responses by regulating P38/STAT3 signaling.
Kim J; Lee HJ; Park JH; Cha BY; Hoe HS
J Neuroinflammation; 2022 Jul; 19(1):187. PubMed ID: 35841100
[TBL] [Abstract][Full Text] [Related]
15. Verbascoside potentiates the effect of tyrosine kinase inhibitors on the induction of apoptosis and oxidative stress via the Abl-mediated MAPK signalling pathway in chronic myeloid leukaemia.
Akgun-Cagliyan G; Cort-Donmez A; Kilic-Toprak E; Altintas F
Exp Ther Med; 2022 Aug; 24(2):514. PubMed ID: 35837042
[TBL] [Abstract][Full Text] [Related]
16. Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19.
Naik RR; Shakya AK; Aladwan SM; El-Tanani M
Front Pharmacol; 2022; 13():806568. PubMed ID: 35444538
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma.
Hedberg ML; Berry CT; Moshiri AS; Xiang Y; Yeh CJ; Attilasoy C; Capell BC; Seykora JT
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408839
[TBL] [Abstract][Full Text] [Related]
18. Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis.
Dorsch M; Kowalczyk M; Planque M; Heilmann G; Urban S; Dujardin P; Forster J; Ueffing K; Nothdurft S; Oeck S; Paul A; Liffers ST; Kaschani F; Kaiser M; Schramm A; Siveke JT; Winslow MM; Fendt SM; Nalbant P; Grüner BM
Cell Rep; 2021 Nov; 37(8):110056. PubMed ID: 34818551
[TBL] [Abstract][Full Text] [Related]
19. Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P; De Dominici M; Salvino J; Calabretta B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573335
[TBL] [Abstract][Full Text] [Related]
20. Imatinib Efficacy, Safety and Resistance in Iranian Patients with Chronic Myeloid Leukemia: A Review of Literature.
Amouei A; Daeian N; Khezrnia SS; Mansouri A; Hadjibabaie M
Int J Hematol Oncol Stem Cell Res; 2021 Apr; 15(2):114-131. PubMed ID: 34466210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
